Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
REGN

Regeneron

$522.02

26.69 (5.39%)

, CELG

Celgene

$132.83

6.61 (5.24%)

08:16
06/22/17
06/22
08:16
06/22/17
08:16
Recommendations
Regeneron, Celgene, Vertex, Alexion, AbbVie, Amgen, Gilead, Biogen analyst commentary at Leerink »

Leerink sees reasons for…

REGN

Regeneron

$522.02

26.69 (5.39%)

CELG

Celgene

$132.83

6.61 (5.24%)

VRTX

Vertex

$134.83

8.5 (6.73%)

ALXN

Alexion

$123.58

4.53 (3.81%)

ABBV

AbbVie

$71.34

0.12 (0.17%)

AMGN

Amgen

$171.35

5.06 (3.04%)

GILD

Gilead

$67.50

1.91 (2.91%)

BIIB

Biogen

$278.60

12.6 (4.74%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jun

  • 06

    Jul

  • 13

    Jul

  • 19

    Jul

  • 25

    Jul

  • 14

    Aug

  • 23

    Oct

  • 03

    Feb

Tuesday
VRTX

Vertex

$125.58

2.44 (1.98%)

13:25
06/20/17
06/20
13:25
06/20/17
13:25
Conference/Events
Vertex participates in a conference call with JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

  • 06

    Jul

VRTX

Vertex

$125.58

2.44 (1.98%)

07:55
06/20/17
06/20
07:55
06/20/17
07:55
Conference/Events
Vertex has conference call hosted by JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

VRTX

Vertex

$125.58

2.44 (1.98%)

04:55
06/20/17
06/20
04:55
06/20/17
04:55
Conference/Events
Vertex participates in a conference call with JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

Monday
VRTX

Vertex

$123.14

-0.9 (-0.73%)

07:46
06/19/17
06/19
07:46
06/19/17
07:46
Conference/Events
Vertex has conference call hosted by JPMorgan »

JPMorgan Biotech Analyst…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

JUNO

Juno Therapeutics

$23.29

0.77 (3.42%)

04:55
06/19/17
06/19
04:55
06/19/17
04:55
Conference/Events
Juno Therapeutics management to meet with Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Sunday
VRTX

Vertex

$123.14

-0.9 (-0.73%)

17:32
06/18/17
06/18
17:32
06/18/17
17:32
Hot Stocks
Vertex granted Orphan designation for tezacaftor-ivacaftor combination »

The FDA granted Vertex…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Jun

  • 21

    Jun

JUNO

Juno Therapeutics

$23.29

0.77 (3.42%)

14:30
06/18/17
06/18
14:30
06/18/17
14:30
Hot Stocks
Juno Therapeutics reports data from 'TRANSCEND' trial of JCAR017 »

Juno Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

MGNX

MacroGenics

$18.24

0.48 (2.70%)

14:15
06/18/17
06/18
14:15
06/18/17
14:15
Hot Stocks
MacroGenics reports updated Phase 1 data on MGD010 »

MacroGenics announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Friday
JUNO

Juno Therapeutics

$22.52

-0.61 (-2.64%)

10:30
06/16/17
06/16
10:30
06/16/17
10:30
Conference/Events
Juno Therapeutics management to meet with Leerink »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.